Sleepiness in Parkinson's Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation

  • STATUS
    Recruiting
  • participants needed
    30
  • sponsor
    Central Hospital, Nancy, France
Send
Updated on 19 February 2024
See if I qualify
brain stimulation
dopamine agonists
parkinson's disease
somnolence
antiparkinsonian agents

Summary

Sleepiness is frequent in parkinsonian patients, increasing with the duration of disease. By patients with motor fluctuations, continuous dopaminergic delivery devices or deep brain stimulation are justified to improve the motor prognosis. Antiparkinsonian treatments, especially dopaminergic agonists, may worsen the sleepiness and thus affect the quality of life. We aimed to monitor sleepiness in parkinsonian patients before and during treatment with continous dopaminergic delivery device or deep brain stimulation.

Details
Condition Parkinson's Disease, Parkinson's Disease
Age 100years or below
Treatment Multiple sleep latency tests
Clinical Study IdentifierNCT04441697
SponsorCentral Hospital, Nancy, France
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

patient with Parkinson's disease and motor fluctuations
and indicated for a continuous dopaminergic delivery device or deep brain stimulation

Exclusion Criteria

age < 18 years
refusal for the continuous dopaminergic delivery device or deep brain stimulation
wake-stimulating drugs intake
refusal to participate
legal protection
uncontrolled sleep apnea
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

brain stimulation
dopamine agonists
parkinson's disease
somnolence
antiparkinsonian agents

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.